Skip to content

Edesa Biotech, Inc.

EDSA

CIK 0001540159

← back to feed
Revenue (TTM)
$109.99K
−100.0% YoY Q2 May 2026
Net Income (TTM)
−$9.81M
−16.5% YoY Q2 May 2026
EPS Diluted (TTM)
−$0.12
−58.3% YoY Q2 May 2026
Gross Margin
98.7%
Q2 May 2026
Operating Margin
-9,256.7%
Q2 May 2026
Net Margin
-8,915.7%
Q2 May 2026
Free Cash Flow (TTM)
−$6.81M
Q2 May 2026
Cash
$10M
Q2 May 2026
Total Debt
—
Q2 May 2026
Shares Outstanding
8.89M sh
Q2 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings